Globus Medical, Inc. Updates Earnings Guidance for the Full Year 2024
May 08, 2024 at 01:45 am IST
Share
Globus Medical, Inc. updated earnings guidance for the full year 2024. The company updated its guidance for full year 2024 revenue in the range of $2.460 billion to $2.485 billion. This updated guidance is an increase over the prior full year 2024 revenue guidance of $2.450 billion to $2.475 billion.
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
GLOBUS MEDICAL, INC. 
